Divergent neuroendocrine responses to localized and systemic inflammation

Seminars in Immunology

Volumn 26, Issue 5, 2014, Pages 402-408

  Lukewich, Mark K ^a   Rogers, Richard C ^b   Lomax, Alan E ^c  

^a BROCK UNIVERSITY   (Canada)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Excitation secretion coupling; Inflammatory bowel disease; Neuroimmunology; Sepsis; Sympathetic nervous system

Indexed keywords

CALCIUM; CATECHOLAMINE; VOLTAGE GATED CALCIUM CHANNEL; CYTOKINE;

ADRENERGIC SYSTEM; CALCIUM SIGNALING; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; ENDOPLASMIC RETICULUM; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; NEGATIVE FEEDBACK; NEUROENDOCRINOLOGY; NONHUMAN; REVIEW; SEPSIS; SYMPATHETIC NERVE CELL; ANIMAL; CHROMAFFIN CELL; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CATECHOLAMINES; CHROMAFFIN CELLS; CYTOKINES; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; NEURONS; SEPSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84922715550     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2014.01.004     Document Type: Review

References (146)

1. Cannon W.B. Organization of physiological homeostasis. Physiol Rev 1929, 9:399-431.
2. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000, 52:595-638.
3. Ignatowski T.A., Gallant S., Spengler R.N. Temporal regulation by adrenergic receptor stimulation of macrophage (M phi)-derived tumor necrosis factor (TNF) production post-LPS challenge. J Neuroimmunol 1996, 65:107-117.
4. Ignatowski T.A., Spengler R.N. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 1995, 61:61-70.
5. Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., Kunkel S.L. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 1994, 152:3024-3031.
6. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 1996, 26:2601-2605.
7. Zinyama R.B., Bancroft G.J., Sigola L.B. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10. Immunology 2001, 104:439-446.
8. Sigola L.B., Zinyama R.B. Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors. Immunology 2000, 100:359-363.
9. Abrass C.K., O'Connor S.W., Scarpace P.J., Abrass I.B. Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 1985, 135:1338-1341.
10. Barnett C.C., Moore E.E., Partrick D.A., Silliman C.C. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release. J Surg Res 1997, 70:166-170.
11. Weiss M., Schneider E.M., Tarnow J., Mettler S., Krone M., Teschemacher A., et al. Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors. J Pharmacol Exp Ther 1996, 278:1105-1113.
12. Borger P., Hoekstra Y., Esselink M.T., Postma D.S., Zaagsma J., Vellenga E., et al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol 1998, 19:400-407.
13. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997, 100:1513-1519.
14. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 1997, 158:4200-4210.
15. Ramer-Quinn D.S., Baker R.A., Sanders V.M. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 1997, 159:4857-4867.
16. Maestroni G.J., Mazzola P. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J Neuroimmunol 2003, 144:91-99.
17. Maestroni G.J. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J Neuroimmunol 2002, 129:106-114.
18. Seiffert K., Hosoi J., Torii H., Ozawa H., Ding W., Campton K., et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002, 168:6128-6135.
19. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 1990, 145:1430-1434.
20. Maestroni G.J. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol 2000, 165:6743-6747.
21. Rosas-Ballina M., Ochani M., Parrish W.R., Ochani K., Harris Y.T., Huston J.M., et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A 2008, 105:11008-11013.
22. Rosas-Ballina M., Olofsson P.S., Ochani M., Valdes-Ferrer S.I., Levine Y.A., Reardon C., et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011, 334:98-101.
23. Bratton B.O., Martelli D., McKinley M.J., Trevaks D., Anderson C.R., McAllen R.M. Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. Exp Physiol 2012, 97:1180-1185.
24. Saper C.B., Romanovsky A.A., Scammell T.E. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat Neurosci 2012, 15:1088-1095.
25. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
26. Coote J.H., Downman C.B., Weber W.V. Reflex discharges into thoracic white rami elicited by somatic and visceral afferent excitation. J Physiol 1969, 202:147-159.
27. Coote J.H., Downman C.B. Central pathways of some autonomic reflex discharges. J Physiol 1966, 183:714-729.
28. Janig W. Autonomic reactions in pain. Pain 2012, 153:733-735.
29. Ibeakanma C., Vanner S. TNFalpha is a key mediator of the pronociceptive effects of mucosal supernatant from human ulcerative colitis on colonic DRG neurons. Gut 2010, 59:612-621.
30. Kidd B.L., Urban L.A. Mechanisms of inflammatory pain. Br J Anaesth 2001, 87:3-11.
31. Chiu I.M., Von Hehn C.A., Woolf C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci 2012, 15:1063-1067.
32. Chiu I.M., Heesters B.A., Ghasemlou N., Von Hehn C.A., Zhao F., Tran J., et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013, 501:52-57.
33. Ochoa-Cortes F., Ramos-Lomas T., Miranda-Morales M., Spreadbury I., Ibeakanma C., Barajas-Lopez C., et al. Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol 2010, 299:G723-G732.
34. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
35. Shu H.F., Wang B.R., Wang S.R., Yao W., Huang H.P., Zhou Z., et al. IL-1beta inhibits IK and increases [Ca2+]i in the carotid body glomus cells and increases carotid sinus nerve firings in the rat. Eur J Neurosci 2007, 25:3638-3647.
36. Watkins L.R., Goehler L.E., Relton J.K., Tartaglia N., Silbert L., Martin D., et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995, 183:27-31.
37. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 1996, 61:287-291.
38. Gordon F.J. Effect of nucleus tractus solitarius lesions on fever produced by interleukin-1beta. Auton Neurosci 2000, 85:102-110.
39. Luheshi G.N., Bluthe R.M., Rushforth D., Mulcahy N., Konsman J.P., Goldbach M., et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 2000, 85:127-132.
40. Hansen M.K., Daniels S., Goehler L.E., Gaykema R.P., Maier S.F., Watkins L.R. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci 2000, 85:83-87.
41. Rogers R.C., Van Meter M.J., Hermann G.E. Tumor necrosis factor potentiates central vagal afferent signaling by modulating ryanodine channels. J Neurosci 2006, 26:12642-12646.
42. Rogers R.C., Hermann G.E. Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci 2012, 32:5237-5241.
43. Kaplan B.L. The role of CB1 in immune modulation by cannabinoids. Pharmacol Ther 2013, 137:365-374.
44. Bienkowski M.S., Rinaman L. Noradrenergic inputs to the paraventricular hypothalamus contribute to hypothalamic-pituitary-adrenal axis and central Fos activation in rats after acute systemic endotoxin exposure. Neuroscience 2008, 156:1093-1102.
45. Elmquist J.K., Saper C.B. Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J Comp Neurol 1996, 374:315-331.
46. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991, 259:988-996.
47. Plotkin S.R., Banks W.A., Kastin A.J. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroimmunol 1996, 67:41-47.
48. Blais V., Rivest S. Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries. J Neuropathol Exp Neurol 2001, 60:893-905.
49. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 2002, 22:5606-5618.
50. Zhang Z.H., Wei S.G., Francis J., Felder R.B. Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 2003, 284:R916-R927.
51. Yu Y., Zhang Z.H., Wei S.G., Serrats J., Weiss R.M., Felder R.B. Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension 2010, 55:652-659.
52. Ryan U.S., Ryan J.W., Smith D.S., Winkler H. Fenestrated endothelium of the adrenal gland: freeze-fracture studies. Tissue Cell 1975, 7:181-190.
53. Hume D.A., Halpin D., Charlton H., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc Natl Acad Sci U S A 1984, 81:4174-4177.
54. Gonzalez-Hernandez J.A., Bornstein S.R., Ehrhart-Bornstein M., Geschwend J.E., Adler G., Scherbaum W.A. Macrophages within the human adrenal gland. Cell Tissue Res 1994, 278:201-205.
55. Judd A.M. Cytokine expression in the rat adrenal cortex. Horm Metab Res 1998, 30:404-410.
56. Morita K., Miyasako T., Kitayama S., Dohi T. Interleukin-1 inhibits voltage-dependent P/Q-type Ca2+ channel associated with the inhibition of the rise of intracellular free Ca2+ concentration and catecholamine release in adrenal chromaffin cells. Biochim Biophys Acta 2004, 1673:160-169.
57. Motagally M.A., Lukewich M.K., Chisholm S.P., Neshat S., Lomax A.E. Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons. J Physiol 2009, 587:2623-2634.
58. Hurst S., Collins S.M. Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves. Am J Physiol 1993, 264:G30-G35.
59. Tachikawa E., Kondo Y., Takahashi M., Kashimoto T., Yanagihara N., Toyohira Y., et al. Interferon-alpha reduces catecholamine secretion from bovine adrenal chromaffin cells stimulated by acetylcholine. Naunyn Schmiedebergs Arch Pharmacol 1997, 356:699-705.
60. Ait-Ali D., Turquier V., Grumolato L., Yon L., Jourdain M., Alexandre D., et al. The proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1 stimulate neuropeptide gene transcription and secretion in adrenochromaffin cells via activation of extracellularly regulated kinase 1/2 and p38 protein kinases, and activator protein-1 transcription factors. Mol Endocrinol 2004, 18:1721-1739.
61. Yanagihara N., Minami K., Shirakawa F., Uezono Y., Kobayashi H., Eto S., et al. Stimulatory effect of IL-1 beta on catecholamine secretion from cultured bovine adrenal medullary cells. Biochem Biophys Res Commun 1994, 198:81-87.
62. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007, 104:13798-13803.
63. Barajon I., Serrao G., Arnaboldi F., Opizzi E., Ripamonti G., Balsari A., et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009, 57:1013-1023.
64. Wadachi R., Hargreaves K.M. Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J Dent Res 2006, 85:49-53.
65. Goethals S., Ydens E., Timmerman V., Janssens S. Toll-like receptor expression in the peripheral nerve. Glia 2010, 58:1701-1709.
66. Riley T.P., Neal-McKinney J.M., Buelow D.R., Konkel M.E., Simasko S.M. Capsaicin-sensitive vagal afferent neurons contribute to the detection of pathogenic bacterial colonization in the gut. J Neuroimmunol 2013, 257:36-45.
67. Lukewich M.K., Lomax A.E. Toll-like receptor 4 activation reduces adrenal chromaffin cell excitability through a nuclear factor-kappaB-dependent pathway. Endocrinology 2013, 154:351-362.
68. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233:652-654.
69. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238:524-526.
70. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987, 238:519-521.
71. Tsagarakis S., Gillies G., Rees L.H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology 1989, 49:98-101.
72. Roh M.S., Drazenovich K.A., Barbose J.J., Dinarello C.A., Cobb C.F. Direct stimulation of the adrenal cortex by interleukin-1. Surgery 1987, 102:140-146.
73. Liu S., Zhu X., Liu Y., Wang C., Wang S., Tang X., et al. Endotoxin tolerance of adrenal gland: attenuation of corticosterone production in response to lipopolysaccharide and adrenocorticotropic hormone. Crit Care Med 2011.
74. Bernstein C.N., Wajda A., Svenson L.W., MacKenzie A., Koehoorn M., Jackson M., et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006, 101:1559-1568.
75. Stange E.F., Travis S.P., Vermeire S., Beglinger C., Kupcinkas L., Geboes K., et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006, 55(Suppl. 1):i1-i15.
76. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
77. Abraham C., Cho J.H. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078.
78. Furlan R., Ardizzone S., Palazzolo L., Rimoldi A., Perego F., Barbic F., et al. Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am J Physiol Regul Integr Comp Physiol 2006, 290:R224-R232.
79. Ganguli S.C., Kamath M.V., Redmond K., Chen Y., Irvine E.J., Collins S.M., et al. A comparison of autonomic function in patients with inflammatory bowel disease and in healthy controls. Neurogastroenterol Motil 2007, 19:961-967.
80. Dong X.X., Thacker M., Pontell L., Furness J.B., Nurgali K. Effects of intestinal inflammation on specific subgroups of guinea-pig celiac ganglion neurons. Neurosci Lett 2008, 444:231-235.
81. Magro F., Vieira-Coelho M.A., Fraga S., Serrao M.P., Veloso F.T., Ribeiro T., et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci 2002, 47:216-224.
82. Motagally M.A., Neshat S., Lomax A.E. Inhibition of sympathetic N-type voltage-gated Ca2+ current underlies the reduction in norepinephrine release during colitis. Am J Physiol Gastrointest Liver Physiol 2009, 296:G1077-G1084.
83. Swain M.G., Blennerhassett P.A., Collins S.M. Impaired sympathetic nerve function in the inflamed rat intestine. Gastroenterology 1991, 100:675-682.
84. Jacobson K., McHugh K., Collins S.M. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995, 109:718-722.
85. Jacobson K., McHugh K., Collins S.M. The mechanism of altered neural function in a rat model of acute colitis. Gastroenterology 1997, 112:156-162.
86. Blandizzi C., Fornai M., Colucci R., Baschiera F., Barbara G., de G.R., et al. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 2003, 139:309-320.
87. Straub R.H., Grum F., Strauch U., Capellino S., Bataille F., Bleich A., et al. Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Gut 2008, 57:911-921.
88. Straub R.H., Stebner K., Harle P., Kees F., Falk W., Scholmerich J. Key role of the sympathetic microenvironment for the interplay of tumour necrosis factor and interleukin 6 in normal but not in inflamed mouse colon mucosa. Gut 2005, 54:1098-1106.
89. Lukewich M.K., Lomax A.E. Altered adrenal chromaffin cell function during experimental colitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G654-G664.
90. ACCP, SCCM Consensus Conference Committee American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
91. Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009, 101:36-47.
92. Groves A.C., Griffiths J., Leung F., Meek R.N. Plasma catecholamines in patients with serious postoperative infection. Ann Surg 1973, 178:102-107.
93. Benedict C.R., Grahame-Smith D.G. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. Q J Med 1978, 47:1-20.
94. Benedict C.R., Rose J.A. Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992, 38:165-172.
95. Annane D., Trabold F., Sharshar T., Jarrin I., Blanc A.S., Raphael J.C., et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med 1999, 160:458-465.
96. Lin I.Y., Ma H.P., Lin A.C., Chong C.F., Lin C.M., Wang T.L. Low plasma vasopressin/norepinephrine ratio predicts septic shock. Am J Emerg Med 2005, 23:718-724.
97. Feuerstein G., Dimicco J.A., Ramu A., Kopin I.J. Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia. J Pharm Pharmacol 1981, 33:576-579.
98. Jones S.B., Yelich M.R. Simultaneous elevation of plasma insulin and catecholamines during endotoxicosis in the conscious and anesthetized rat. Life Sci 1987, 41:1935-1943.
99. Qi M., Zhou Z.Z., Wurster R.D., Jones S.B. Mechanisms involved in the rapid dissipation of plasma epinephrine response to bacterial endotoxin in conscious rats. Am J Physiol 1991, 261:R1431-R1437.
100. Hershey J.C., Bond R.F. The influence of sympathoadrenal activation on skeletal muscle oxygen extraction during endotoxemia. Shock 1994, 1:115-122.
101. Hahn P.Y., Wang P., Tait S.M., Ba Z.F., Reich S.S., Chaudry I.H. Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 1995, 4:269-273.
102. Kovarik M.F., Jones S.B., Romano F.D. Plasma catecholamines following cecal ligation and puncture in the rat. Circ Shock 1987, 22:281-290.
103. Prager R.L., Dunn E.L., Seaton J.F. Increased adrenal secretion of norepinephrine and epinephrine after endotoxin and its reversal with corticosteroids. J Surg Res 1975, 18:371-375.
104. McKechnie K., Dean H.G., Furman B.L., Parratt J.R. Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: effects of adrenal demedullation and/or guanethidine treatment. Circ Shock 1985, 17:85-94.
105. Spink W.W., Reddin J., Zak S.J., Peterson M., Starzecki B., Seljeskog E. Correlation of plasma catecholamine levels with hemodynamic changes in canine endotoxin shock. J Clin Invest 1966, 45:78-85.
106. Mills E. Development of the sympathetic nervous system response to endotoxicosis in the rat: importance of non-baroreflex mechanisms in pre-weanlings and adults. J Dev Physiol 1990, 13:99-103.
107. Tkacs N.C., Strack A.M. Systemic endotoxin induces Fos-like immunoreactivity in rat spinal sympathetic regions. J Auton Nerv Syst 1995, 51:1-7.
108. Zhou Z.Z., Jones S.B. Involvement of central vs. peripheral mechanisms in mediating sympathoadrenal activation in endotoxic rats. Am J Physiol 1993, 265:R683-R688.
109. Jones S.B., Kotsonis P., Majewski H. Endotoxin enhances norepinephrine release in the rat by peripheral mechanisms. Shock 1994, 2:370-375.
110. Lukewich M.K., Lomax A.E. Endotoxemia enhances catecholamine secretion from male mouse adrenal chromaffin cells through an increase in Ca2+ release from the endoplasmic reticulum. Endocrinology 2014, 155:180-192.
111. Fairchild K.D., Saucerman J.J., Raynor L.L., Sivak J.A., Xiao Y., Lake D.E., et al. Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1019-R1027.
112. Alex P., Zachos N.C., Nguyen T., Gonzales L., Chen T.E., Conklin L.S., et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009, 15:341-352.
113. Karaplis A.C., Funk C.D., Powell W.S. Binding of prostaglandin E2 to cultured bovine adrenal chromaffin cells and its effect on catecholamine secretion. Biochim Biophys Acta 1989, 1010:369-376.
114. Gulpinar M.A., Ozbeyli D., Arbak S., Yegen B.C. Anti-inflammatory effect of acute stress on experimental colitis is mediated by cholecystokinin-B receptors. Life Sci 2004, 75:77-91.
115. Robertson D.A., Ray J., Diamond I., Edwards J.G. Personality profile and affective state of patients with inflammatory bowel disease. Gut 1989, 30:623-626.
116. Saunders P.R., Miceli P., Vallance B.A., Wang L., Pinto S., Tougas G., et al. Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat. Auton Neurosci 2006, 124:56-68.
117. Lechin F., van der Dijs B., Insausti C.L., Gomez F., Villa S., Lechin A.E., et al. Treatment of ulcerative colitis with clonidine. J Clin Pharmacol 1985, 25:219-226.
118. Mueller R.A., Thoenen H., Axelrod J. Adrenal tyrosine hydroxylase: compensatory increase in activity after chemical sympathectomy. Science 1969, 163:468-469.
119. Thoenen H., Tranzer J.P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1968, 261:271-288.
120. Kolibal-Pegher S., Edwards D.J., Meyers-Schoy S.A., Vollmer R.R. Adrenal medullary adaptations and cardiovascular regulation after 6-hydroxydopamine treatment in rats. J Auton Nerv Syst 1994, 48:113-120.
121. McCafferty D.M., Wallace J.L., Sharkey K.A. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol 1997, 272:G272-G280.
122. Martinolle J.P., More J., Dubech N., Garcia-Villar R. Inverse regulation of alpha- and beta-adrenoceptors during trinitrobenzenesulfonic acid (TNB)-induced inflammation in guinea-pig small intestine. Life Sci 1993, 52:1499-1508.
123. Bai A., Lu N., Guo Y., Chen J., Liu Z. Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol 2009, 156:353-362.
124. Poon Y.Y., Chang A.Y., Chan S.H. Differential contribution of N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors in the intermediolateral cell column of the thoracic spinal cord to sympathetic vasomotor tone during experimental endotoxemia in the rat. Shock 2006, 26:372-378.
125. Falk A., Myrvold H.E., Haglund U. Sympathetico-adrenergic influences on the small intestinal vascular reactions in experimental septic shock. Acta Physiol Scand 1983, 119:373-379.
126. Bosmann M., Meta F., Ruemmler R., Haggadone M.D., Sarma J.V., Zetoune F.S., et al. Regulation of IL-17 family members by adrenal hormones during experimental sepsis in mice. Am J Pathol 2013, 182:1124-1130.
127. Solomon S.B., Banks S.M., Gerstenberger E., Csako G., Bacher J.D., Thomas M.L., et al. Sympathetic blockade in a canine model of gram-negative bacterial peritonitis. Shock 2003, 19:215-222.
128. Bolton W.K., Atuk N.O. Study of chemical sympathectomy in endotoxin-induced lethality and fibrin depostion. Kidney Int 1978, 13:263-270.
129. Nakada T.A., Russell J.A., Boyd J.H., Aguirre-Hernandez R., Thain K.R., Thair S.A., et al. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med 2010, 181:143-149.
130. Walker-Brown J., Roberts M.R. Differential contribution of beta-adrenergic receptors expressed on radiosensitive versus radioresistant cells to protection against inflammation and mortality in murine endotoxemia. Shock 2009, 32:541-547.
131. Elenkov I.J., Hasko G., Kovacs K.J., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 1995, 61:123-131.
132. Schmitz D., Wilsenack K., Lendemanns S., Schedlowski M., Oberbeck R. beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 2007, 72:286-294.
133. Ackland G.L., Yao S.T., Rudiger A., Dyson A., Stidwill R., Poputnikov D., et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 2010, 38:388-394.
134. Hagiwara S., Iwasaka H., Maeda H., Noguchi T. Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 2009, 31:515-520.
135. Szelenyi J., Kiss J.P., Puskas E., Selmeczy Z., Szelenyi M., Vizi E.S. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. Neuroreport 2000, 11:3565-3568.
136. Miksa M., Das P., Zhou M., Wu R., Dong W., Ji Y., et al. Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS ONE 2009, 4:e5504.
137. Zhang F., Wu R., Qiang X., Zhou M., Wang P. Antagonism of alpha2A-adrenoceptor: a novel approach to inhibit inflammatory responses in sepsis. J Mol Med 2010, 88:289-296.
138. Yang S., Zhou M., Chaudry I.H., Wang P. Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol 2001, 281:G1014-G1021.
139. Brede M., Nagy G., Philipp M., Sorensen J.B., Lohse M.J., Hein L. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol Endocrinol 2003, 17:1640-1646.
140. Dubin A., Pozo M.O., Casabella C.A., Palizas F., Murias G., Moseinco M.C., et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 2009, 13:R92.
141. Jhanji S., Stirling S., Patel N., Hinds C.J., Pearse R.M. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009, 37:1961-1966.
142. Marik P.E., Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994, 272:1354-1357.
143. Mackenzie S.J., Kapadia F., Nimmo G.R., Armstrong I.R., Grant I.S. Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport. Intensive Care Med 1991, 17:36-39.
144. Martin C., Viviand X., Leone M., Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000, 28:2758-2765.
145. Dunser M.W., Ruokonen E., Pettila V., Ulmer H., Torgersen C., Schmittinger C.A., et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care 2009, 13:R181.
146. Schmittinger C.A., Dunser M.W., Torgersen C., Luckner G., Lorenz I., Schmid S., et al. Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock 2013, 39:329-335.